Comparative placebo-controlled clinical trials on the efficiency and safety of ultralow doses of antibodies to human IFN-γ (anaferon pediatric formulation and anaferon) and prophylaxis of bacterial complication showed that administration of these preparations in complex therapy of bacterial infection reduced the incidence of bacterial complications of viral infections and considerably decreased the duration of the main clinical symptoms of the disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
I. V. Babachenko, Modern Clinical and Laboratory Peculiarities of Pertussis Infections in Children. Author’s Synopsis of Doct. Med. Sciences Dissertation [in Russian], St. Petersburg (2007).
K. V. Verevshchikov, V. m. Borzunov, and E. K. Shemyakina, Infekts. Bolizni, 5, No. 3, 67–69 (2007).
M. V. Kudin, Yu. N. Fedorov, A. V. Skripkin, et al., Detskie Infektsii, No. 4, 61–68 (2007).
V. N. Timchenko, N. M. Kalinina, and M.E. Khmylova, Urgent Problems of Infectious Pathology in Children (Diagnostics and Therapy). Theses of IV Congress of Russian Pediatricians Infectionists [in Russian], Moscow (2005), pp. 174–175.
V. K. Tatochenko, Consilium Medicus, Suppl. 1, (2004), pp. 3–6.
K. I. Chuikiva and L. A. Zhuravleva, Detskie Infektsii, 5, No. 3, 66–69 (2006).
Author information
Authors and Affiliations
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 148, Suppl. 1, pp. 43–44, August, 2009
Rights and permissions
About this article
Cite this article
Tarasov, S.A., Kachanova, M.V., Zhavbert, E.S. et al. Application of Ultralow Doses of Antibodies to Interferon-γ in Complex Therapy of Bacterial Infections and Prophylaxis of Bacterial Complications. Bull Exp Biol Med 148, 295–296 (2009). https://doi.org/10.1007/s10517-009-0699-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-009-0699-4